HIGHLIGHTS
- who: Yuan-Yuan Liu from the Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Key Laboratory of Early Prevention The People`s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China have published the research: MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients, in the Journal: (JOURNAL)
- what: This research provides novel insights that miR-320b and miR-320d as biomarkers can predict the response to platinum-based chemotherapy for better therapy regimens in ovarian cancer patients, as well as probably participate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.